Sanuwave Announces Q3 FY2025 Financial Results
Q3 2025 revenues were $11.5 million, up 22% from $9.4 million in Q3…
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared…
uniQure to Announce Third Quarter 2025 Financial Results
LEXINGTON, Mass. and AMSTERDAM, Nov. 06, 2025 (GLOBE NEWSWIRE) -- uniQure N.V.…
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 05, 2025 08:00 ET | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine…
Baylor Genetics to Highlight Genetic Testing Use Cases and Advancements in Rare Disease at The National Society of Genetic Counselors 44th Annual Conference
HOUSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic…
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
Automobili Lamborghini confirms its solidity over the first nine months of 2025
Resilient results in a complex global environment demonstrate the strength of the…
Xinhua Silk Road: Annual Conference of Financial Street Forum 2025 concludes with fruitful results
BEIJING, Nov. 3, 2025 /PRNewswire/ -- The Annual Conference of Financial Street…
Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET | Source: Belite Bio, Inc MHRA response…